Compound Radar

Certara, Inc. (CERT) Stock Analysis

Price $7.74
Market cap $1.18B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

45
45/100 Speculative
  • Financial Health 30
  • Profitability 40
  • Business Quality 75
  • Balance Sheet 55
  • Cash Flow 60

Why this rating?

Health 45/100 — Speculative

Strongest Business Quality 75/100
Softest Financial Health 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Certara, Inc. (CERT) is a Health Information Services company in the Healthcare sector. Compound Radar rates Certara, Inc. 45/100 (Speculative) due to high business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Fair

Financial highlights

Valuation

  • Forward P/E 19.8
  • EV/Revenue 3.15

Profitability

  • Revenue Growth 1.0%
  • Gross Margin 61.6%
  • Operating Margin -0.2%
  • Net Margin -16.2%
  • ROE -2.2%

Financial strength

  • Cash $184.87M
  • Debt $301.94M
  • Net Cash $-117.08M
  • Free Cash Flow $69.77M
  • Current Ratio 2.55

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Certara, Inc. (CERT).

View Methodology & FAQ →